The present invention relates to a novel sortase A (SrtA) inhibitory compound N-(2-(3-oxobenzo[d]isothiazol-2(3H)-yl)acetyl)adamantane-1-carbohydrazide which can be used in medicine as anti-infective agent for treating Gram-positive bacterial infection.